欢迎使用我们的服务!
限时优惠,立即购买享受折扣
24小时客服在线,随时为您服务
优质产品,值得信赖

NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma

NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma

Final draft guidance recommends D‑VRd on the NHS in England and Wales